Do monoclonal antibodies Tü15 and Tü67 detect heterogeneity of human transferrin receptor molecules?  by Uchańska-Ziegler, Barbara et al.
Volume 175, number 2 FBBS 1801 October 1984 
Do monoclonal antibodies TiilS and Tii67 detect 
heterogeneity of human transferrin receptor molecules? 
Barbara Uchahska-Ziegler, Peter Wet-net, Shi Liangru and Andreas Ziegler 
Immunology Laboratory, Medizinbche Klinik. Abt. II, University of Tiibingen, D-7400 Tiibingen, FRG 
Received 16 July 1984 
The possible molecular heterogeneity of human transferrin receptors was nalyzed using two murine mono- 
clonal antibodies, TiilS and Tii67. Both reagents precipitated from lysates of 124-labeled HL-60 cells a major 
component of 88 kDa which could be identified as the transferrin receptor by comparison with the proteins 
detected by monoclonal antibody OKT9. Although sequential immunoprecipitations appeared to demon- 
strate molecular heterogeneity of transferrin receptors, since the TtilS-reactive species were fully included 
in the Tii67-positive population, but not vice versa, the possible association of TiilS-reactive molecules with 
transferrin receptor is also discussed. 
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1. INTRODUCTION 
Transferrin is the major serum iron-transport 
protein and plays an essential role in the 
maintenance of growth of continuous cell lines in 
culture [l]. It has been suggested that the expres- 
sion of the receptor for transferrin on the surface 
of such cells correlates positively with proliferation 
and activation and is independent of the cell cycle 
[2-41. Several monoclonal antibodies (MOABs) 
have been produced against his molecule [5-71, at 
least one of which appears to react preferentially 
with transferrin receptors (TRs) on early erythroid 
cells [8]. However, molecular heterogeneity of this 
membrane antigen has never been conclusively 
demonstrated. We describe two MOABs which 
have been employed in sequential im- 
munoprecipitation experiments. The results sug- 
gest that human TR is molecularly heterogeneous, 
but the possible association of another molecule 
recognized by one of these MOABs with TR is also 
considered. 
line HL-60 [9] and HP- 1, a somatic hybrid between 
HL-60 and the Burkitt’s lymphoma-derived cell 
line P3HRl [lo], were maintained under standard 
culture conditions. The MOAB TiilS (IgM) was 
produced by fusing P3-NS l/l -Ag4- 1 murine 
myeloma cells [l l] with spleen cells from a 
BALB/c mouse previously immunized with nor- 
mal human thymocytes, and in the case of Tii67 
(IgG), an ILZdriven human T-cell line was the im- 
munogen [ 121. All hybrid cell lines were cloned at 
least twice to assure monoclonality. The MOAB 
OKT9 is directed against TR molecules [ 131 and 
was purchased from Ortho Pharmaceutical. A rab- 
bit antiserum (tiH) was raised against HL-60 cells 
by a combination of subcutaneous and intravenous 
injections of intact cells. It was then absorbed ex- 
tensively on HP-1 cells until only HL-60, but not 
HP-l cells were still recognized. Normal rabbit 
serum served as negative control. 
2. MATERIALS AND METHODS 
The human promyelocytic leukemia-derived cell 
HL-60 cells were labeled with Na’251 and lysed 
as described in [14]. 100 pl of lysate (2 x lo6 
trichloroacetic acid-precipitable cpm) were in- 
cubated for 30 min at 4°C with an equal volume of 
MOAB-containing culture supernatant or 50 ~1 of 
rabbit antiserum after which 40~1 of a 10% 
Staphylococcus aureus strain Cowan I suspension 
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were added. For immunoprecipitations with 
MOABs, these bacteria were coated with affinity- 
purified goat anti-mouse IgG (or IgM) [ 151. Final- 
ly, the bacterial pellet was washed 5 x with 
phosphate-buffered saline and resuspended in 
sample buffer [la]. For sequential im- 
munoprecipitations, 500 ~1 lysate were first 
precleared 3 x with TiilS, Tii67 or rabbit an- 
tiserum; the supernatant of the last precipitation 
was aliquoted and treated again with all reagents 
used. Normal rabbit serum (NRS) was used as 
negative control. SDS-polyacrylamide gel elec- 
trophoresis (SDS-PAGE) was done on 7% slab 
gels under reducing conditions [ 161 and molecular 
mass markers (New England Nuclear) were em- 
ployed. All gels were autoradiographed on Fuji 
RX films. 
3. RESULTS 
The MOABs TiilS and Tii67 as well as OKT9 
reacted with all HL-60 cells; however, when these 
cells were induced to differentiate towards 
macrophages or granulocytes, all 3 antibodies 
ceased to react with the non-dividing, differen- 
tiated cells [17] (not shown). Since TRs disappear 
from the cell surface of non-proliferating cells, it 
was possible that this protein was the target of the 
MOABs. A comparison of the material 
precipitated by Tii67 and OKT9 showed that the 
molecular species recognized by the two MOABs 
were indistinguishable (fig.lA). In each case, a ma- 
jor band of 88000 Da, the TR molecule [6,7], was 
precipitated together with minor bands of Iw, 
180ooO,155000 and 145000, presumably dimers of 
the receptor and receptor-transferrin complexes. 
An additional band at 76000 Da might be transfer- 
rin itself. Sequential immunoprecipitation using 
Tii67 as first reagent proved that Tii67 and OKT9 
detected identical molecules (not shown), since the 
Tii67-depleted lysate did not contain OKT9-re- 
active molecules any longer. By comparison with 
Tii67, Till 5 also recognized human TRs, but much 
less cpm could be observed in the 88000 Da band 
(fig.lB). When Tiil5 and Tii67 were added simul- 
taneously, the amount of radioactivity in the TR 
band resembled that seen with Tii67 alone. The 
I&H serum directed against HL-60 cells was ab- 
sorbed with HP-1 cells, because these had been 
found to lack a variety of cell surface molecules 
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Fig.1. Autoradiograph of 7% SDS gels of 
immunoprecipitates from ‘2’I-labeled HL-60 cells under 
reducing conditions. Positions of molecular mass 
standards are indicated (200 kDa, myosin; 92.5 kDa, 
phosphorylase b; 68 kDa, bovine serum albumin; 43 
kDa, ovalbumin). 
specific for myeloid cells [lo]. The resulting an- 
tiserum precipitated several molecules, but by far 
the major band again appeared to be TR (fig.lB). 
Sequential immunoprecipitations were used to 
analyze the relationship of the molecules detected 
by Tiil5, Tii67 and bH serum (figs 2,3). Three 
cycles of precipitation with Tiil5 were sufficient to 
completely eliminate the molecules recognized by 
this MOAB (fig.ac), but both Tii67 and RaH were 
still able to detect TR proteins (fig.2d,e). However, 
when Tii67 was used as first reagent, not only the 
Tii67-positive molecules were removed as expected 
(fig.2j), but also the proteins recognized by Tiil5 
(fig.2i) and those bands precipitated by RcrH 
(fig.2k) which correlate in molecular mass with the 
molecules detected by Tii67 (see fig.lB). When 
Tii 15 and Tii67 were employed simultaneously for 
the preprecipitation (fig.fg-1), the result was no 
different from that obtained with Tii67 alone. The 
RcvH serum also recognized TR, since no TiilS- or 
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Fig.2. Sequential immunoprecipitation of molecules recognized by TtilS, lX67 and &H from 1Z51-labeled HL-60 cell 
lysate. Autoradiograph of 7% SDS gels. Lanes: a-c, first, second and third precipitation respectively with Tiil5; d, 
TiilS-depleted cell lysate precipitated wlth Tii67; e, exactly as line d, but precipitation with ILUH; f, NRS control. Lanes: 
g,h,j, first, second and third precipitation respectively with Tii67; i, Tii67-depleted cell lysate precipitated with TtilS; 
k, exactly as i but precipitation with RruH; 1, NRS control. All samples were reduced. 
Ti.i67-reactive proteins remained in the lysate after 
depletion with the xenoantiserum (fig.3a-f). 
4. DISCUSSION 
The results presented here show that it is easily 
possible to produce a conventional antiserum with 
preferential activity against human TR. This serum 
will be useful in in vitro translation studies, since 
MOABs often fail to recognize the proteins syn- 
thesized in these systems 1181. However, what ap- 
Rears more interesting at this point is the molecular 
complexity of human TR detected by MOABs. 
Differential reactivity of certain MOABs directed 
against TR has been shown before using various 
bone marrow-derived cells [S], but two types of TR 
on a given celi have so far not been described. The 
sequential immunoprecipitation experiments how 
that the receptor population detected by TiilS is 
only part of that recognized by Tii67 or RoH 
serum. Since TiilS and Ttl67 each react with 100% 
of uninducecl HL-60 cells, the differential activity 
of Ttil5 to the receptor molecules cannot be due to 
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Fig.3. Autoradiograph of 7% SDS gel as in fig.2, Lanes: a,b,e, first, second and third precipitation with tiH s( 
c, RcrH-depleted cell lysate precipitated with TiilS; d, as lane c, but precipitation with Tti67; f, NRS control, L 
g,h, first and second precipitation with TiilS + Tii67; i, TiilS + Tti67-depleted cell lysate precipitated with Tii 
as lane i, but precipitation with Tu67; k, as lane i, but precipitation with RcrH; 1, NRS control. 
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reactivity of this MOAB with only a subpopulation 
of cells. It is also highly unlikely that weak affinity 
of TtllS is responsible for the restricted activity 
observed, since after 3 cycles of preprecipitation, 
no TiilS-positive molecules could be detected, 
although TR proteins could be easily demonstrated 
in the depleted lysate by using Ttl67 or RCVH 
serum. Therefore, the simplest conclusion would 
be that Till5 and Tti67 distinguish two types of 
human TR. An alternative possibility might be that 
TtilS detects a molecule of similar size to TR and 
complexed to the latter, but distinct. This may lend 
the TR functional heterogeneity with regard to cell 
growth and differentiation. 
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